Chengjie Xiong

Jiangxi University of Traditional Chinese Medicine — China

Medicine · Health Sciences

61h-index16.2kcitations351works6.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Dementia and Cognitive Impairment Research(184), Alzheimer's disease research and treatments(138), Functional Brain Connectivity Studies(39), Spine and Intervertebral Disc Pathology(31), Bioinformatics and Genomic Networks(27)

Publications346 total

The Knight Alzheimer Research Imaging (KARI) dataset: a comprehensive multimodal resource for exploring aging, preclinical, and symptomatic Alzheimer disease pathology
2025Open Access
Remote Digital Cognitive Assessment in a Trial-Ready Alzheimer’s Cohort: A Scalable Approach for Early Intervention Studies
2025Open Access
Clinical efficacy and radiological outcomes of a novel screw placement technique for the treatment of traumatic thoracolumbar vertebral fractures under navigation guidance
BMC Musculoskeletal Disorders·2025Open Access
A – 101 Quantifying Cognitive Change across One Year in REM Sleep Behavior Disorder: A Preliminary Analysis of North American Prodromal Synucleinopathy (NAPS) Consortium Study.
Archives of Clinical Neuropsychology·2025
Person-specific digital measurements of air pollutant exposure and biomarkers of Alzheimer's disease: Findings from a pilot study
Journal of Alzheimer s Disease·2025· 3 citedOpen Access
Comprehensive workflow with optical navigation in minimally invasive transforaminal lumbar interbody fusion: a retrospective study
Journal of Orthopaedic Surgery and Research·2025· 1 citedOpen Access
Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease
Acta Neuropathologica·2025· 3 citedOpen Access
Causal Impact of Immune Phenotypes on Herpes Zoster and Postherpetic Neuralgia: Insights from Mendelian Randomization Analysis
Clinical Cosmetic and Investigational Dermatology·2025Open Access
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial
The Lancet Neurology·2025· 27 cited
Longitudinal changes of blood-brain barrier and transcytolemmal water exchange permeability in Alzheimer's disease mice: A non-contrast MRI study
NeuroImage·2025· 7 citedOpen Access
Study of Conductive Nerve Conduits for Anti-Inflammatory and Antioxidant Effects
SSRN Electronic Journal·2025Open Access
CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
Alzheimer s & Dementia·2024Open Access
Cognitive reserve influences symptom onset and longitudinal decline in Dominantly Inherited Alzheimer's Disease
Alzheimer s & Dementia·2024· 1 citedOpen Access
CSF proteomics related to the neurovascular unit are associated with white matter hyperintensity volumes and cerebral microhemorrhages in autosomal dominant Alzheimer disease
Alzheimer s & Dementia·2024Open Access
CSF proteomics related to the neurovascular unit are associated with white matter hyperintensity volumes and cerebral microhemorrhages in autosomal dominant Alzheimer disease
Alzheimer s & Dementia·2024Open Access
CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
Alzheimer s & Dementia·2024Open Access
Consistent classification of amyloid status by fasted and non‐fasted plasma Aβ42/40 and Amyloid Probability Score
Alzheimer s & Dementia·2024Open Access
Longitudinal Changes of BBB Permeability and transcytolemmal permeability in Alzheimer’s Disease Mice: A Non-Contrast MRI Study
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2024
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer’s disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial
2024· 4 citedOpen Access
Longitudinal associations between exercise and biomarkers in autosomal dominant Alzheimer's disease
Alzheimer s & Dementia·2024· 5 citedOpen Access
page 1 of 18Next →

Frequent Co-authors

John C. Morris(42), Anne M. Fagan(25), Tammie L.S. Benzinger(24), Randall J. Bateman(23), David M. Holtzman(19), Eric McDade(16), Brian A. Gordon(15), Stephen Salloway(14), John M. Ringman(13), Alison Goate(12), Colin L. Masters(12), Jason Hassenstab(11), Peter R. Schofield(11), Martin R. Farlow(10), Jasmeer P. Chhatwal(10), Virginia Buckles(9), Nick C. Fox(9), Sarah Berman(8), Ralph N. Martins(8), Bernardino Ghetti(8)